A detailed history of Strs Ohio transactions in Guardant Health, Inc. stock. As of the latest transaction made, Strs Ohio holds 10,100 shares of GH stock, worth $294,011. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,100
Previous 10,100 -0.0%
Holding current value
$294,011
Previous $291,000 20.62%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$16.07 - $31.84 $197,661 - $391,632
-12,300 Reduced 54.91%
10,100 $291,000
Q1 2024

May 13, 2024

SELL
$17.13 - $26.91 $23,982 - $37,674
-1,400 Reduced 5.88%
22,400 $462,000
Q4 2023

Jan 30, 2024

BUY
$21.58 - $29.5 $82,004 - $112,100
3,800 Added 19.0%
23,800 $643,000
Q2 2023

Jul 31, 2023

BUY
$20.94 - $38.01 $418,800 - $760,200
20,000 New
20,000 $716,000
Q2 2021

Jul 26, 2021

SELL
$109.77 - $165.68 $1.19 Million - $1.79 Million
-10,823 Closed
0 $0
Q1 2021

Apr 23, 2021

BUY
$127.04 - $179.1 $294,859 - $415,691
2,321 Added 27.3%
10,823 $1.65 Million
Q4 2020

Jan 25, 2021

BUY
$99.96 - $135.93 $113,054 - $153,736
1,131 Added 15.34%
8,502 $1.1 Million
Q3 2020

Dec 14, 2020

SELL
$80.32 - $111.8 $63,051 - $87,763
-785 Reduced 9.62%
7,371 $823,000
Q2 2020

Jul 23, 2020

BUY
$60.49 - $97.5 $181,772 - $292,987
3,005 Added 58.34%
8,156 $661,000
Q1 2020

Apr 23, 2020

SELL
$59.04 - $88.81 $3,188 - $4,795
-54 Reduced 1.04%
5,151 $358,000
Q4 2019

Jan 24, 2020

BUY
$59.49 - $82.78 $139,325 - $193,870
2,342 Added 81.8%
5,205 $406,000
Q3 2019

Oct 21, 2019

BUY
$62.59 - $110.3 $179,195 - $315,788
2,863 New
2,863 $182,000
Q2 2019

Jul 25, 2019

SELL
$63.94 - $91.11 $722,522 - $1.03 Million
-11,300 Closed
0 $0
Q1 2019

Apr 19, 2019

BUY
$34.3 - $97.98 $253,819 - $725,052
7,400 Added 189.74%
11,300 $866,000
Q4 2018

Jan 23, 2019

BUY
$29.2 - $46.1 $113,880 - $179,790
3,900 New
3,900 $146,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.98B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.